Australia’s CDD Cures Crohn’s Disease

Drug Discovery |  News | 1 Comment | 15 Apr, 2020

The Centre for Digestive Disease (CDD) headed by Professor Thomas Borody has cured Crohn’s Disease as reported on ...Read more

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

Drug Discovery |  News | 0 Comment | 10 Apr, 2020

Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...Read more

Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy

Drug Discovery |  News | 0 Comment | 10 Apr, 2020

Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...Read more

I-Mab to develop TJM2 for treatment of COVID-19 related illness

Drug Discovery |  News | 0 Comment | 26 Mar, 2020

I-Mab Biopharma, a clinical stage biopharmaceutical company committed to the discovery, development and commercializatio...Read more

CytomX, Astellas to find cure for cancer

Drug Discovery |  News | 0 Comment | 25 Mar, 2020

US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...Read more

China clears Taletrectinib IND, issues clinical trial authorizations

Drug Discovery |  News | 0 Comment | 24 Mar, 2020

AnHeart Therapeutics, a clinical stage oncology company focused on underserved patients in global markets, has anno...Read more

Bayer, Curadev ink €250M deal for novel STING antagonists

Drug Discovery |  News | 0 Comment | 24 Mar, 2020

Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, on 23 March 2020 announced a research collaboratio...Read more

Japan approves Novartis' SMA drug

Drug Discovery |  News | 0 Comment | 19 Mar, 2020

Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...Read more

Beijing Tide Pharma collaborates with Insilico for cancer therapy

Drug Discovery |  News | 0 Comment | 18 Mar, 2020

Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Med...Read more

Japan to test AIM ImmunoTech’s Ampligen for COVID-19

Drug Discovery |  News | 0 Comment | 10 Mar, 2020

AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...Read more

Atomwise, Bridge Bio sign $1B Deal

Drug Discovery |  News | 0 Comment | 12 Mar, 2020

US based Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, and South Korea based ...Read more

Takeda initiates development of Plasma-Derived Therapy for COVID-19

Drug Discovery |  News | 0 Comment | 05 Mar, 2020

Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...Read more

Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Drug Discovery |  News | 1 Comment | 27 Feb, 2020

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (ge...Read more

Arctoris launches BioTarget 2020 to support biotech company innovations

Drug Discovery |  News | 0 Comment | 21 Feb, 2020

Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has...Read more

Codagenix & Serum Institute to co-develop vaccine against Novel Coronavirus

Drug Discovery |  News | 0 Comment | 14 Feb, 2020

Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies h...Read more

China's Borui Biomedical imitates Gilead's Coronavirus drug

Drug Discovery |  News | 1 Comment | 14 Feb, 2020

Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. announced that it has successfully developed and synthesizes the technology ...Read more

Gilead begins trial for coronavirus drug

Drug Discovery |  News | 0 Comment | 12 Feb, 2020

US based biotech company Gilead is working with health authorities in China to establish a randomized, controlled trial ...Read more

Bridge Biotherapeutics acquires new candidate for back-eye diseases

Drug Discovery |  News | 0 Comment | 06 Feb, 2020

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea has acquired ...Read more